Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
10.13
+0.84 (9.04%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Immix Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Net Income | -23.56 | -21.61 | -15.43 | -8.23 | -24.38 | -1.15 | Upgrade
|
| Depreciation & Amortization | 0.32 | 0.12 | 0.01 | 0 | 0 | 0 | Upgrade
|
| Other Amortization | - | - | - | - | 0.06 | - | Upgrade
|
| Stock-Based Compensation | 2.58 | 3.02 | 2.57 | 0.62 | 0.22 | - | Upgrade
|
| Other Operating Activities | - | -0.08 | -0.17 | - | 22.91 | 0.58 | Upgrade
|
| Change in Accounts Payable | 4.1 | 4.4 | 2.43 | 1.13 | -0.11 | -0 | Upgrade
|
| Change in Income Taxes | 1.82 | -0.97 | -0.89 | -0.24 | 0.1 | 0.06 | Upgrade
|
| Change in Other Net Operating Assets | 0.37 | 0.54 | 0.11 | -0.7 | -0.38 | 0.11 | Upgrade
|
| Operating Cash Flow | -14.38 | -14.6 | -11.37 | -7.41 | -1.59 | -0.4 | Upgrade
|
| Capital Expenditures | -1.07 | -1.18 | -0.05 | - | -0 | - | Upgrade
|
| Investing Cash Flow | -1.07 | -1.18 | -0.05 | - | -0 | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 0.2 | - | Upgrade
|
| Total Debt Issued | - | - | - | - | 0.2 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -0.05 | - | - | Upgrade
|
| Total Debt Repaid | - | - | - | -0.05 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -0.05 | 0.2 | - | Upgrade
|
| Issuance of Common Stock | 11.89 | 15.95 | 15.52 | 2.91 | 18.65 | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | -0.1 | - | - | Upgrade
|
| Other Financing Activities | -0.17 | - | -0.06 | 0.47 | - | - | Upgrade
|
| Financing Cash Flow | 11.72 | 15.95 | 15.46 | 3.23 | 18.85 | - | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.01 | -0 | 0.03 | -0.03 | -0.01 | 0.06 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | 0 | - | - | - | - | Upgrade
|
| Net Cash Flow | -3.74 | 0.17 | 4.07 | -4.21 | 17.25 | -0.34 | Upgrade
|
| Free Cash Flow | -15.45 | -15.77 | -11.42 | -7.41 | -1.59 | -0.4 | Upgrade
|
| Free Cash Flow Per Share | -0.51 | -0.56 | -0.66 | -0.53 | -0.43 | -0.12 | Upgrade
|
| Cash Interest Paid | - | - | - | 0.01 | 0 | 0 | Upgrade
|
| Cash Income Tax Paid | - | - | - | - | - | 0.02 | Upgrade
|
| Levered Free Cash Flow | -6.58 | -7.55 | -5.94 | -4.31 | -2.1 | 0.39 | Upgrade
|
| Unlevered Free Cash Flow | -6.58 | -7.55 | -5.94 | -4.31 | -2.04 | 0.46 | Upgrade
|
| Change in Working Capital | 6.29 | 3.97 | 1.65 | 0.2 | -0.39 | 0.17 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.